It contributes to strengthening the antioxidant defence system by eliminating free radicals and toxins in your body
JH: Data curation, Formal analysis, Methodology, Supervision, Writing original draft
In reality, these formulations address tangential pathways rather than the GLP-1 receptor itself
Future trials could help elucidate other potential benefits of GLP-1 drugs beyond sugar control
SEE ALSO: FDA approves 2 gene editing therapies that may cure sickle cell disease Calls about semaglutide stand out in the data in other way, too
But where semaglutide acts on one receptor (the glucagon-like peptide-1, or GLP-1, receptor), and tirzepatide on two (GLP-1 and the gastric inhibitory polypeptide, or GIP, receptors), retatrutide has been nicknamed Triple G for its ability to work on three hormone receptors (those for GLP-1 and GIP, as well as the glucagon, or GCG, receptor)